WuXi Biology Fact Sheet
- Expertise in all major disease areas and all major target classes, enabling discovery for all therapeutic modalities
- World class antiviral platform with an unequalled service capability and capacity in HBV and other viral diseases
- A global leader in DNA Encoded Library (DEL) screening, with innovative business models
- CAP-certified pathology and FACS capabilities supporting clinical biomarker services
- The world’s leading integrated, on-line, tumor model database
WuXi Biology Fact Sheet
Related Content
The recent publication in the journal Organic Letters, 'DNA-Compatible Cyclization Reaction to Access 1,3,4-Oxadiazoles & 1,2,4-Triazoles' by our WuXi Biology...
VIEW RESOURCEIntroduction: Targeted Protein Degradation (TPD) has emerged as a promising therapeutic modality due to its potential to develop therapeutics for...
VIEW RESOURCE